6-K

Commission File Number 001-31914

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

April 21, 2021

China Life Insurance Company Limited

(Translation of registrant’s name into English)

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-             

Commission File Number 001-31914

On April 21, 2021, China Life Insurance Company Limited issued an announcement on estimated profit increase for the first quarter of 2021, a copy of which is attached as Exhibit 99.1 hereto.

Certain statements contained in this announcement may be viewed as “forward-looking statements” within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of the Company to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. Further information regarding these risks, uncertainties and other factors is included in the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019 filed with the U.S. Securities and Exchange Commission, or SEC, on April 29, 2020 and in the Company’s other filings with the SEC. You should not place undue reliance on these forward-looking statements. All information provided in this announcement is as of the date of this announcement, unless otherwise stated, and we undertake no duty to update such information, except as required under applicable law. Unless otherwise indicated, the Chinese insurance market information set forth in this announcement is based on public information released by the China Banking and Insurance Regulatory Commission.

EXHIBIT LIST

Exhibit	Description
99.1	Announcement, dated April 21, 2021

Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		China Life Insurance Company Limited
		(Registrant)
	By:	/s/ Su Hengxuan
		(Signature)
April 21, 2021	Name:	Su Hengxuan
	Title:	President and Executive Director

EX-99.1

Exhibit 99.1

ANNOUNCEMENT

ESTIMATED PROFIT INCREASE FOR THE FIRST QUARTER OF 2021

This announcement is made by the Company pursuant to the provisions of inside information under Part XIVA of the SFO and Rule 13.09(2) of the Listing Rules.

Based on the Company’s preliminary estimates, it is estimated that the net profit attributable to equity holders of the Company for the first quarter of 2021 will increase by a range between approximately RMB9,400 million and RMB12,818 million as compared to the same period of 2020 (representing an increase of approximately 55% to 75%). The Company’s preliminary financial estimates for the first quarter of 2021 contained in this announcement are not audited. Detailed financial information of the Company for the first quarter of 2021 will be disclosed in the Company’s 2021 first quarter report.

Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

This announcement is made by China Life Insurance Company Limited (the “Company”) pursuant to the provisions of inside information under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong) (the “SFO”) and Rule 13.09(2) of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Listing Rules”).

I. Estimated results during this period

1. Estimated results period: 1 January 2021 to 31 March 2021

2. Estimated results: Based on the Company’s preliminary estimates, it is estimated that the net profit attributable to equity holders of the Company for the first quarter of 2021 will increase by a range between approximately RMB9,400 million and RMB12,818 million as compared to the same period of 2020 (representing an increase of approximately 55% to 75%). It is estimated that the net profit attributable to equity holders of the Company after deducting non-recurring items for the first quarter of 2021 will increase by a range between approximately RMB9,416 million and RMB12,840 million as compared to the same period of 2020 (representing an increase of approximately 55% to 75%).

1

3. The estimated results have not been audited.

II. Results for the same period of 2020 (unaudited)

1. Net profit attributable to equity holders of the Company: RMB17,090 million;

Net profit attributable to equity holders of the Company after deducting non-recurring items: RMB17,120 million

2. Earnings per share (basic and diluted): RMB0.60

III. Main reasons for the estimated increase in results

The estimated increase in the results for the first quarter of 2021 is mainly attributable to the impact of investment income. The Company constantly optimized its investment management system and strengthened its capability of asset allocation and professional investment in specific products. In the first quarter of 2021, the Company well managed strategic allocation and tactical operations based on market conditions, enriched fixed-income investment products, actively managed the equity exposure and achieved a significant increase in investment income.

IV. Risk warning

There are no material uncertain factors of the Company that might affect the accuracy of its estimated results for the first quarter of 2021.

V. Other information

The Board of Directors of the Company wishes to remind shareholders and investors that the above estimated results for the first quarter of 2021 contained in this announcement are based on the Company’s preliminary estimates, which are subject to the Company’s further examination and are not audited. If the Company’s future estimates of the results of the first quarter of 2021 differ materially from the above estimates, the Company will provide updates on a timely basis. Detailed financial information of the Company for the first quarter of 2021 will be disclosed in the Company’s 2021 first quarter report.

Shareholders of the Company and potential investors are advised to exercise caution when dealing in the shares of the Company.

By Order of the Board

China Life Insurance Company Limited

Heng Victor Ja Wei

Company Secretary

Hong Kong, 21 April 2021

2

As at the date of this announcement, the Board of Directors of the Company comprises:

Executive Directors:	Wang Bin, Su Hengxuan, Li Mingguang
Non-executive Directors:	Yuan Changqing, Wang Junhui
Independent Non-executive Directors:	Chang Tso Tung Stephen, Robinson Drake Pike, Tang Xin, Leung Oi-Sie Elsie

3